Loading…
US stock · US markets · public data
VRTX
Vertex Pharmaceuticals Inc · Healthcare
Reference price$526.19Updated according to the public source
P/E30.61
P/B6.58
ROE23.54%
DY 12M—
Net margin34.69%
Debt/equity0.10
Market capUS$ 133.4 B
Volume (shares)1,400,000
SectorHealthcare
Overview
Indicadores públicos consolidadosAbout VRTX
Vertex Pharmaceuticals Inc (VRTX) is a stock traded in US markets in the Healthcare sector. P/E 30.61, P/B 6.58, ROE 23.54% and dividend yield not disclosed. The P/E multiple helps compare this asset's valuation with other companies in the same sector. Explore the public market data tracked by FundamentalRadar. This page includes key fundamental indicators, recent distributions and financial statements available from the public sources tracked by FundamentalRadar.
Distributions
public dataDividends and distributions · last 12 records
The source returned no recent distributions for this asset.
Financials
No dataIncome statement, balance sheet and cash flow
Financial statements are not available for this asset yet.
FAQ
Frequently asked questions
What is the price of VRTX?
The current price of VRTX is $526.19.
What is the P/E of VRTX?
The P/E ratio of VRTX is 30.61, meaning investors pay 30.61 times earnings per share.
What is the P/B of VRTX?
The P/B of VRTX is 6.58, meaning the stock trades at 6.58 times its book value per share.
What is the ROE of VRTX?
The ROE (Return on Equity) of VRTX is 23.54%, meaning the company generates 23.54% of profit for every unit of shareholders' equity.
What is the market cap of VRTX?
The market capitalization of VRTX is US$ 133.4 B.
What is the net margin of VRTX?
The net profit margin of VRTX is 34.69%, meaning the company keeps 34.69% of revenue as profit.
What is the debt-to-equity ratio of VRTX?
The debt-to-equity ratio of VRTX is 0.10, meaning the company has 0.10 units of debt for each unit of equity.
What sector is VRTX in?
VRTX operates in the Healthcare sector.